CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Malaysia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Malaysian pharmaceutical market is one of the major markets in the South East Asian region. It was valued at $1.55B in 2010, which increased to $3.46 in 2013. However, since 2015 it decreased to reach an estimated $1.94B in 2018. The decline was due to the launch of several generic drugs in the market along with the depreciation of the Malaysian Ringgit against the US Dollar. However, rising income, demographic changes and high incidence of non-communicable diseases (NCDs) are expected to drive the market in the future. The Malaysian medical device market was worth $1.28B in 2015, which increased to $1.55B in 2018. It is expected to grow at a CAGR of 9.5% from $1.74B in 2019 to $2.28B in 2022

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Malaysia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, Pfizer, Novartis, GSK, and Duopharma).
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Malaysia
- Porter’s five forces analysis for pharmaceutical and medical devices market of Malaysia
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Malaysian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Malaysian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Malaysian healthcare market